At Piramal Pharma Solutions, we stand as a premier global CDMO, passionately committed to providing comprehensive, end-to-end solutions that span the entire drug lifecycle. From the initial spark of drug discovery to the crucial stages of commercial manufacturing, we are your trusted partner in bringing life-changing medicines to patients worldwide.

Our integrated suite of services is meticulously designed to support every step of your pharmaceutical journey. We offer seamless solutions encompassing drug discovery, the intricate development and manufacturing of drug substances (APIs), and the formulation and manufacturing of diverse drug products across various dosage forms.

Recognizing the evolving complexities of modern medicine, we have cultivated specialized expertise in cutting-edge areas such as antibody-drug conjugates, sophisticated peptides, and vital vaccines. Our commitment extends beyond pharmaceuticals into nutrition solutions, where we provide high-quality products for human and animal health, innovative skincare ingredients, and essential components for food programs.

Our global reach is a testament to our dedication to serving our partners wherever they may be. With 15 strategically located facilities across North America, Europe, and Asia, we offer a robust and reliable infrastructure to support your diverse needs. These state-of-the-art sites are equipped to handle a wide spectrum of manufacturing requirements, including specialized capabilities for high potency APIs, sterile injectables, oral solids, and complex antibody-drug conjugates.

We continuously invest in our capabilities to meet the growing demands of the industry. Our Riverview, USA facility stands as a center of excellence for high-potency API manufacturing. Furthermore, our recent announcement of an $80 million expansion for our sterile injectables facility in Lexington, Kentucky, underscores our commitment to bolstering our capacity in biologics manufacturing. This significant expansion, slated for completion by Q1 2027, will add 24,000 square feet of advanced manufacturing space, a cutting-edge laboratory, and the latest in pharmaceutical machinery.

Quality is at the heart of everything we do. Our unwavering commitment is reflected in the 340+ regulatory inspections and 1740+ customer audits our facilities have successfully undergone. We adhere to a rigorous three-tier quality governance process, ensuring the highest standards at every stage of development and manufacturing.

Our strength lies in our dedicated team of over 4,700 professionals. We foster a culture driven by patient centricity, the power of integrated solutions, the advantage of our global footprint, and a deep-rooted science-driven approach. Our "Science Collective," comprising esteemed thought leaders and subject matter experts, fuels innovation and ensures we remain at the forefront of pharmaceutical advancements. We are proud to serve over 500 valued customers across the globe.

Recent developments highlight our strategic focus. We are committed to organic growth, optimizing our operational efficiency, and diligently reducing our debt. We also actively explore synergistic partnerships in the OTC market to broaden our impact. The recent marketing approval in the UK for Neoatricon, a critical care medication developed in collaboration between Piramal Critical Care and BrePco Biopharma, underscores our dedication to addressing unmet patient needs. Furthermore, the expansion of our antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland, significantly enhances our capacity to produce these vital targeted therapies.

Our comprehensive capabilities encompass the entire drug development lifecycle. Our drug discovery services include advanced synthetic chemistry, insightful in-vitro biology, thorough in-vitro ADME studies, efficient route scouting, and seamless non-GMP scale-up. In API development and manufacturing, we offer specialized expertise in handling high potency APIs, complex peptide APIs, and hormonal APIs. Finally, our formulation development and commercial manufacturing services cover a wide array of dosage forms, including convenient oral solids, versatile liquids, topical creams and ointments, and critical sterile injectables.

At Piramal Pharma Solutions, we are more than just a CDMO; we are your dedicated partner, driven by science and committed to making a meaningful difference in the lives of patients. We invite you to explore how our integrated solutions and global expertise can help you achieve your pharmaceutical goals.

Piramal Pharma Solutions offers a comprehensive suite of services, broadly categorized as follows:

• Drug Discovery: This includes services related to the initial stages of drug development.
• Drug Substance: Encompasses the development and manufacturing of active pharmaceutical ingredients (APIs).
• Drug Product: Covers the formulation and manufacturing of the final drug product in various dosage forms.
• Specialized Offerings: This includes services in niche areas like antibody-drug conjugates, peptides, and vaccines.
• Nutrition Solutions: This encompasses products for human and animal health, skincare ingredients, and food programs.